Algo version: 0.98b
Parenteral Drugs (India) is listed at the NSE Exchange
Parenteral Drugs (India) [PDPL.NS]
NSE Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is Parenteral Drugs (India) stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Parenteral Drugs (India) pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Monday 13th of September 2010 were paid INR1.12503 per share. Over the last 1 times between 2010 and 2010, Parenteral Drugs (India) has paid INR1.12503 with an average of INR1.13 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Parenteral Drugs (India) 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR3.60, you would have made a loss of INR-0.700 per share or -19.44%

We do not have enough data to give you this answer.

Parenteral Drugs (India) has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Parenteral Drugs (India) to be high [0.85 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.